Clinical Trial Update: Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated the mechanism of action of sitagliptin in patients with Type 2 diabetes mellitus, with results posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Status: COMPLETED | Results posted: 2011-05-16